A hotspot phosphorylation site on SHP2 drives oncoprotein activation and drug resistance

In this work, authors show that phosphorylation of SHP2 at Y62 by SRC family kinases drives resistance to allosteric SHP2 inhibitors by enforcing SHP2 in an open and active conformation, mimicking oncogenic function and sustaining MAPK signaling.